Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
HANLY ANN M.
EVP & Chief Technology Officer at Vir Biotechnology. Filing since 29 Nov 2021.
CIK 0001854528
Company
Date
Role
Action
Shares
Amount
Of holding
VIR
Vir Biotechnology, Inc.
24 Feb 2025
EVP & Chief Technology Officer
Sold on a plan
14,168
$133.94K
10.7%
VIR
Vir Biotechnology, Inc.
1 Apr 2024
EVP & Chief Technology Officer
Sold on a plan
2,711
$27.25K
2.0%
VIR
Vir Biotechnology, Inc.
22 Feb 2024
EVP & Chief Technology Officer
Sold on a plan
12,296
$123.52K
8.4%
VIR
Vir Biotechnology, Inc.
30 Mar 2023
Chief Technology Officer
Sold at will
2,627
$59.82K
2.2%
VIR
Vir Biotechnology, Inc.
23 Feb 2023
Chief Technology Officer
Sold, plan not stated
2,302
$59.79K
1.9%
VIR
Vir Biotechnology, Inc.
30 Mar 2022
Chief Technology Officer
Sold, plan not stated
2,627
$68.93K
3.1%
VIR
Vir Biotechnology, Inc.
29 Nov 2021
Chief Technology Officer
Bought
12
$499.85
opened
7 decisions on file.
